In a phenome-wide association study of the UK Biobank data, Lumsden et al. found that APOE4 carriers were at increased odds for AD and ischemic heart disease, and decreased odds for gallbladder disease and liver disease compared to non-carriers32. This evidence concerns the gene APOE and liver disorder.